YEWB — Yew Bio-Pharm Cashflow Statement
0.000.00%
Last trade - 00:00
Basic MaterialsHighly SpeculativeMicro Cap
- $0.01m
- $8.98m
- $27.31m
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.01 | 3.21 | -1.32 | 0.986 | 1.46 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.48 | 2.25 | 9.07 | 7.03 | 11.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.8 | -11.8 | 13.7 | 2.11 | 1.99 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 0.643 | -2.62 | 32.5 | 12 | 17.3 |
Capital Expenditures | -0.062 | -0.799 | -32.8 | -14.7 | -12.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.296 | 0 | — | 0.013 | -4.59 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.235 | -0.799 | -32.8 | -14.7 | -17.4 |
Financing Cash Flow Items | -0.049 | -0.171 | 0 | 0.059 | 0.026 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.26 | 3.92 | 0.026 | 2.9 | -0.014 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.403 | 0.581 | -0.338 | 0.221 | -0.178 |